Etoposide Injection
Product Images NDC 16729-114

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Etoposide (NDC 16729-114). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Accord Healthcare Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

12.5 mL Carton Label (Etoposide Carton 12.5ml)

Packaging label for Etoposide Injection USP by Accord Healthcare Inc. The label shows a concentration of 20 mg/mL with a total volume of 12.5 mL (250 mg/12.5 mL). It includes instructions that the drug must be diluted before IV infusion and notes it is a cytotoxic agent. The label specifies it is a multiple-dose vial and lists key inactive ingredients along with storage conditions.*

FDA Label Image

25 mL Carton Label (Etoposide Carton 25ml)

Packaging label for Etoposide Injection USP by Accord Healthcare Inc. The label shows 500 mg/25 mL (20 mg/mL) strength, intended for intravenous use. It is a 25 mL multiple dose vial with warnings including 'must be diluted before IV infusion,' 'Rx Only,' and 'Caution: Cytotoxic Agent.' The label includes manufacturer and barcode details.*

FDA Label Image

50 mL Carton Label (Etoposide Carton 50ml)

Packaging label for Etoposide Injection USP 20 mg/mL, 1 g/50 mL multiple dose vial, manufactured for Accord Healthcare Inc. The label includes dosage form (injection), route (intravenous), dilution requirement, cytotoxic caution, inactive ingredients, storage conditions, and barcode.*

FDA Label Image

5ml Carton Label (Etoposide Carton 5ml)

Box label for Etoposide Injection USP 100 mg/5 mL (20 mg/mL) by Accord Healthcare Inc. The label states it is a 5 mL multiple dose vial for intravenous infusion, with a caution that it is a cytotoxic agent requiring dilution before use. Includes NDC 16729-114-31 and manufacturing information for Intas Pharmaceuticals Limited, India, with storage and usage instructions.*

FDA Label Image

Structural Formula (Etoposide Struc)

Chemical structure of Etoposide, showing its molecular configuration with multiple ring systems, hydroxyl groups, and methoxy substituents.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.